News

Paris Brain Institute is proud to be celebrating 20 years of partnership with its first and longest-standing private funder: the watchmaking company F.P.Journe. This partnership, based on shared values of trust, loyalty and excellence, has seen F.P ...

The European Research Council's (ERC) Starting Grants are prestigious and highly competitive awards, designed to enable young scientists to build their research team, and to carry out ambitious and innovative projects addressing unexplored scientific ...

What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them ...

On Wednesday July 31, the Institute had the pleasure of welcoming a special group of visitors: members of the International Olympic Committee (IOC) and their friends and families. ...

Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain ...

It was a long-awaited event. On Sunday June 9, 2024, Paris Brain Institute welcomed an incredible piece of technology into its facilities: the latest generation MAGNETOM Terra X (Siemens Healthineers) 7T MRI. Teams have been doing a great deal of ...

As part of the Future Investment Program (PIA) and France 2030, the State and the Île-de-France region launched the IFPAI call for projects (Engineering of professional training and innovative support offers) in 2021. The EPICA project is a winner ...

Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol ...

With support from the Anne and Claude Berda Foundation and from Indosuez Wealth Management, Paris Brain Institute is launching the second edition of NeurAL, its startup studio program. ...

In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and ...

In 2024, Paris Brain Institute launched the 4th edition of the Big Brain Theory Program (BBT), designed to foster new and bold projects addressing the next challenges in neuroscience. For the first time, this call is open to our international ...

When a patient is admitted to intensive care due to a disorder of consciousness—such as a coma—establishing their neurological prognosis is a crucial yet challenging task. To reduce the uncertainty that precedes the medical decision, a group of ...